LAN2C_RUMFL
ID LAN2C_RUMFL Reviewed; 71 AA.
AC P0DQL5;
DT 12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT 12-AUG-2020, sequence version 1.
DT 25-MAY-2022, entry version 4.
DE RecName: Full=Lantibiotic Flvbeta.c {ECO:0000303|PubMed:27028884};
DE Flags: Precursor;
GN Name=FlvA2.c {ECO:0000303|PubMed:27028884};
OS Ruminococcus flavefaciens.
OC Bacteria; Firmicutes; Clostridia; Eubacteriales; Oscillospiraceae;
OC Ruminococcus.
OX NCBI_TaxID=1265;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], EXPRESSION IN E.COLI, DEHYDRATION AT
RP SER-36, AND LANTHIONINE AND METHYLLANTHIONINE CROSS-LINKS.
RC STRAIN=FD-1;
RX PubMed=27028884; DOI=10.1016/j.chembiol.2015.11.014;
RA Zhao X., van der Donk W.A.;
RT "Structural characterization and bioactivity analysis of the two-component
RT lantibiotic Flv system from a ruminant bacterium.";
RL Cell Chem. Biol. 23:246-256(2016).
CC -!- FUNCTION: Lanthionine-containing peptide antibiotic (lantibiotic) that
CC is probably active on Gram-positive bacteria, since its analog
CC [Del1]Flvbeta.c shows antibacterial activity against M.luteus
CC (PubMed:27028884). This activity is not synergistically enhanced by
CC [Del2]Flvalpha.a, an analog of Flvalpha.a, which is encoded by the same
CC operon than Flvbeta.c (PubMed:27028884). The bactericidal activity of
CC lantibiotics is based on depolarization of energized bacterial
CC cytoplasmic membranes, initiated by the formation of aqueous
CC transmembrane pores (By similarity). {ECO:0000250|UniProtKB:P86475,
CC ECO:0000269|PubMed:27028884}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC -!- PTM: Contains LL-lanthionine and DL-beta-methyllanthionine, when
CC coepressed in E.coli with the flavecin synthetase FlvM2.
CC {ECO:0000269|PubMed:27028884}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DQL5; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-KW.
DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
PE 3: Inferred from homology;
KW Antibiotic; Antimicrobial; Bacteriocin; Lantibiotic; Secreted;
KW Thioether bond.
FT PROPEP 1..33
FT /note="Cleaved by FlvT"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450400"
FT PEPTIDE 34..71
FT /note="Lantibiotic Flvbeta.c"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450401"
FT MOD_RES 36
FT /note="2,3-didehydroalanine (Ser); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 35..39
FT /note="Lanthionine (Ser-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 54..60
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 62..65
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
FT CROSSLNK 66..69
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM2"
FT /evidence="ECO:0000305|PubMed:27028884"
SQ SEQUENCE 71 AA; 7656 MW; F0837E218ABD2BE2 CRC64;
MENKFDMEKF KKLAAVVSED ELDTLLDETT VGAGSSNDCA DLILKITGVV VSATSKFDWC
PTGACTTSCR F